Matches in Wikidata for { <http://www.wikidata.org/entity/Q58617859> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q58617859 description "article scientifique publié en 2018" @default.
- Q58617859 description "artículu científicu espublizáu en payares de 2018" @default.
- Q58617859 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58617859 description "scientific article published on 22 November 2018" @default.
- Q58617859 description "wetenschappelijk artikel" @default.
- Q58617859 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q58617859 name "Hyponatremia and MAP-kinase inhibitors in malignant melanoma: frequency, pathophysiological aspects and clinical consequences" @default.
- Q58617859 name "Hyponatremia and MAP-kinase inhibitors in malignant melanoma: frequency, pathophysiological aspects and clinical consequences" @default.
- Q58617859 type Item @default.
- Q58617859 label "Hyponatremia and MAP-kinase inhibitors in malignant melanoma: frequency, pathophysiological aspects and clinical consequences" @default.
- Q58617859 label "Hyponatremia and MAP-kinase inhibitors in malignant melanoma: frequency, pathophysiological aspects and clinical consequences" @default.
- Q58617859 prefLabel "Hyponatremia and MAP-kinase inhibitors in malignant melanoma: frequency, pathophysiological aspects and clinical consequences" @default.
- Q58617859 prefLabel "Hyponatremia and MAP-kinase inhibitors in malignant melanoma: frequency, pathophysiological aspects and clinical consequences" @default.
- Q58617859 P1433 Q58617859-1A05C227-8C9B-4DD7-86FA-A373F320D7A7 @default.
- Q58617859 P1476 Q58617859-35CAAC21-EB8F-4489-9EE6-C1887AD071CC @default.
- Q58617859 P2093 Q58617859-6E95371E-7DF5-4E44-B29B-2773A21F3BC4 @default.
- Q58617859 P2093 Q58617859-7A87B4FB-6F0D-4363-B2B4-3DEC601BCC67 @default.
- Q58617859 P2093 Q58617859-A99166B4-C92B-4FEF-B3BA-AF760C263D94 @default.
- Q58617859 P2093 Q58617859-ABFAA75A-C89D-4F67-A53E-10F01A5E8E04 @default.
- Q58617859 P2093 Q58617859-AC102F0F-5B2C-40EA-A802-082CCA6D2D19 @default.
- Q58617859 P2093 Q58617859-D31ADCEE-8244-4252-A45B-C793D2C8B6DF @default.
- Q58617859 P2093 Q58617859-EABCE2B1-DB00-4B7F-BA36-BEF0EA043773 @default.
- Q58617859 P304 Q58617859-7155AD91-92B8-4C3E-92E5-BB0A60CA5E2B @default.
- Q58617859 P31 Q58617859-5DCF1842-70D7-4C78-BA25-8D1FFB2C5F34 @default.
- Q58617859 P356 Q58617859-79741969-5ADC-44C3-950F-F3832E962BAF @default.
- Q58617859 P407 Q58617859-578CE072-5510-4F6D-BE16-3A73357080AB @default.
- Q58617859 P433 Q58617859-E5E6D9D1-0DCD-4E07-86D3-ED5B07BE1FAF @default.
- Q58617859 P478 Q58617859-9C45C88D-A083-4D3F-B9E5-BF751A6F27A6 @default.
- Q58617859 P50 Q58617859-F0C2FDE7-F147-4098-8252-26E802EA0FC1 @default.
- Q58617859 P577 Q58617859-DE82547F-1332-4FEF-BFBA-08BD259F8F4C @default.
- Q58617859 P698 Q58617859-41A37304-8C28-4612-A4DB-F77E698A1622 @default.
- Q58617859 P921 Q58617859-5FAE6949-5ADE-4CDF-B2CD-F0C3B5DBB10F @default.
- Q58617859 P921 Q58617859-8F3342B1-3310-4FD5-9E29-93BD2DCC8975 @default.
- Q58617859 P356 PCMR.12749 @default.
- Q58617859 P698 30387922 @default.
- Q58617859 P1433 Q762851 @default.
- Q58617859 P1476 "Hyponatremia and MAP-kinase inhibitors in malignant melanoma: Frequency, pathophysiological aspects and clinical consequences" @default.
- Q58617859 P2093 "Alexandre Seidowsky" @default.
- Q58617859 P2093 "Christine Longvert" @default.
- Q58617859 P2093 "Eve Vilaine" @default.
- Q58617859 P2093 "Isabelle Bourgault-Villada" @default.
- Q58617859 P2093 "Philippe Saiag" @default.
- Q58617859 P2093 "Sandra Wagner" @default.
- Q58617859 P2093 "Ziad A Massy" @default.
- Q58617859 P304 "326-331" @default.
- Q58617859 P31 Q13442814 @default.
- Q58617859 P356 "10.1111/PCMR.12749" @default.
- Q58617859 P407 Q1860 @default.
- Q58617859 P433 "2" @default.
- Q58617859 P478 "32" @default.
- Q58617859 P50 Q90000732 @default.
- Q58617859 P577 "2018-11-22T00:00:00Z" @default.
- Q58617859 P698 "30387922" @default.
- Q58617859 P921 Q1135939 @default.
- Q58617859 P921 Q824292 @default.